Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-041471

Chief Financial Officer sold 3,762 shares at $41.80 ($157,252)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Prasad Raju Chief Financial Officer 2025-03-14 Option exercise +10,000 16,476 D
Prasad Raju Chief Financial Officer 2025-03-17 Sale −3,762 $41.80 $157,252 12,714 D
Derivatives
Prasad Raju Chief Financial Officer 2025-03-14 Option exercise · Restricted Stock Units −10,000 20,000 D
Prasad Raju Chief Financial Officer 2025-03-14 Grant or award · Stock Option (Right to Buy) +36,666 36,666 D
Prasad Raju Chief Financial Officer 2025-03-14 Grant or award · Restricted Stock Units +27,500 27,500 D
Open-market sales · 3,762 sh · avg $41.80 · $157,252
Loading xslF345X05/ownership.xml…